Every 6 seconds someone in the world is diagnosed with diabetes. In 2017, an estimated 425 million adults worldwide were living with diabetes. If the current trend continues, it is estimated that this number will increase to 629 million by 2045. This is equivalent to 1 in 10 adults.
As the incidence of diabetes increases worldwide, so does that of its complications, including those affecting the eye. Diabetic retinopathy (DR) can result in impaired vision or blindness. DR affects an estimated one in three people living with diabetes and is a leading cause of avoidable vision loss and blindness in the working-age population.
By 2030, about 191 million people living with diabetes are estimated to develop diabetic retinopathy. Current estimates show 56.3 million people deteriorating to vision-threatening DR if immediate and appropriate steps are not taken.
Regular eye screening is essential for all people with diabetes and should therefore be an integral component of routine diabetes care provided by primary healthcare providers. However, geography and limited resources make eye screening difficult in many countries.
To facilite the provision of eye screening in low-income and/or remote settings, the International Diabetes Federation (IDF) has purchased a first consignment of 100 fundoscopic cameras for distribution to 56 sites identified by IDF Members. The aim is to provide diabetes centres and their personnel with the essential medical equipment to screen people living with diabetes for DR to help manage and prevent this common and costly complication.
The project also intends to improve data collection and increase the available data on diabetic eye disease worldwide.
The 5K@IDF brings together citizens of Busan and IDF 2019 delegates to emphasize the need for increased physical activity to help prevent diabetes and diabetes complications. This disease awareness activity raises awareness about the importance of a healthy lifestyle in preventing type 2 diabetes and managing all types of diabetes.
The relationship between the healthcare professional and the pharmaceutical industry is based on an exchange of information and this is what the IDF Congress is all about.
We believe in the value of face-to-face education and personal exchange. This will again be showcased at the IDF Congress 2019 in Busan, Korea - 2- 6 December 2019 - which will provide opportunities for peer-to-peer interactions with representatives from all sectors of the global diabetes community.
Whether you joined us at past IDF Congresses or consider participating for the first time, we firmly believe that the IDF Congress 2019 in Busan will be beneficial for both you and our delegates.
The IDF Congress has become one of the largest international medical events in diabetes, bringing together thousands of healthcare professionals, hundreds of world-renowned speakers, more than 50 national and international exhibitors and representatives from IDF’s member network in over 160 countries.
The IDF 2019 programme will feature up to ten parallel sessions spread over various streams, tackling all aspects of diabetes, from Basic and Clinical Science to Education and Public Health to Advocacy and Living with diabetes. The IDF congress also provides young researchers with exposure to an international professional audience, allowing them to become multipliers in their region and daily practice.
A virtual walkwill familiarize yourself with BEXCO, the IDF 2019 venue. The IDF Congress will stretch across the Auditorium, the Convention Hall and Exhibition Center I. All relevant statistics to help you better understand the IDF 2019 audience and programme is available in our congress library.
We look forward to welcoming you to the IDF Congress 2019 in Busan, Korea. For additional information and queries, please contact:
As global awareness of Diabetic Retinopathy (DR) has increased so too has the development of resources and tools to assist health care providers in the early detection and treatment of this growing public health problem associated with the rising prevalence of diabetes. However, few of these resources have focused on providing insight into innovative approaches to integrating eye health with diabetes management and control, across the health care spectrum.
For this reason the ‘Integrated care for diabetes and eye health: A global compendium of good practice’ has been developed. It documents a series of ‘realworld’ case studies that showcase current initiatives to advance integrated care for DR across the spectrum of health promotion, prevention, early intervention and treatment in a range of different contexts and resource settings.
The compendium has been designed to help fill a crucial knowledge gap and to strengthen the existing evidence base by providing insights on a range of different models, lessons learned and key recommendations on how to effectively implement integrated care.
Drawing on evidence from a range of projects and programmes showing promising results from 17 countries, the document provides guidance to policy makers, medical organisations, service providers and social investors.
The intended outcome is that decision makers and practitioners will be able to build on the findings and learnings presented in this report to implement their own strategic and tactical approaches to addressing the challenges of blindness and vision loss from diabetes.
Ultimately, it is our hope that those living with or at risk of DR around the world will be able to access the support they need, when and where they need it.